Targeting that receptor could provide earlier, more impactful treatments for retinopathy of prematurity.
Diabetic retinopathy is a major neurovascular complication of diabetes that affects 7.7 million working-age adults in the United States.
Targeting that receptor could provide earlier, more impactful treatments for retinopathy of prematurity.
Diabetic retinopathy is a major neurovascular complication of diabetes that affects 7.7 million working-age adults in the United States.